Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Author(s):
Marianna Fontana
,
Added:
6 days ago
Video Series
Author(s):
Maki Komiyama
Added:
1 month ago
Lipid-lowering Therapies and Lp(a)
Author(s):
Stephen Nicholls
,
Adam J Nelson
Added:
3 weeks ago
Review Article
Systematic Scoping on DOACS in NVAF Patients
Author(s):
Shirley Siang Ning Tan
,
Wei Hong Lai
,
Lee Len Tiong
,
et al
Added:
9 months ago
Review Article
Author(s):
Yimeng Zhang
,
Nimai Desai
,
Derek Connolly
Added:
1 year ago
Author(s):
Christina Magnussen
Added:
1 year ago
ACC 2025 - Individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potentially benefit life-years for freedom from CVD and death from any cause.Prof Christina Magnussen (University Heart and Vascular Centre Hamburg, Hamberg, DE) joins us onsite at ACC to discuss modifiable cardiovascular risk factors collected by the Global…
View more
Chan Hong
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Raúl Ludeña
,
Raúl Ptaszynski Lanza
,
Beatriz Nieves Ureña
,
et al
Added:
1 month ago
Author(s):
María Iglesias Alonso
,
Jose Manuel Iglesias Sanmartin
Added:
1 month ago
Frailty and Cardiovascular Risk
Author(s):
Nicholas R Evans
,
Shiv Bhakta
,
Claudia Zeicu
,
et al
Added:
2 weeks ago
Review Article